APA (7th ed.) Citation

Liu, C., Sun, H., Huang, W., Wang, Z., Fu, C., Han, D., . . . Li, B. (2023). Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy. Frontiers in Immunology, 14, . https://doi.org/10.3389/fimmu.2023.1193394

Chicago Style (17th ed.) Citation

Liu, Chengxin, Hongfu Sun, Wei Huang, Zhongtang Wang, Chengrui Fu, Dan Han, Qian Zhao, Xue Wu, and Baosheng Li. "Sintilimab as Maintenance Treatment for Local/regional Recurrent Esophageal Squamous Carcinoma After Concurrent Chemoradiotherapy." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1193394.

MLA (9th ed.) Citation

Liu, Chengxin, et al. "Sintilimab as Maintenance Treatment for Local/regional Recurrent Esophageal Squamous Carcinoma After Concurrent Chemoradiotherapy." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1193394.